Geode Capital Management, LLC Vir Biotechnology, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,196,601 shares of VIR stock, worth $21.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,196,601

Previous 2,188,774 0.36%

Holding current value

$21.6 Million

Previous $16.4 Million 1.65%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$6.74 - $10.17 $52,753 - $79,600	7,827 Added 0.36%	2,196,601 $16.1 Million
Q3 2024 Nov 12, 2024	BUY	$7.26 - $10.7 $37,359 - $55,062	5,146 Added 0.24%	2,188,774 $16.4 Million
Q2 2024 Aug 09, 2024	BUY	$7.63 - $12.66 $1.79 Million - $2.97 Million	234,439 Added 12.03%	2,183,628 $19.4 Million
Q1 2024 May 13, 2024	BUY	$8.6 - $11.9 $540,019 - $747,236	62,793 Added 3.33%	1,949,189 $19.7 Million
Q4 2023 Feb 13, 2024	BUY	$7.76 - $10.29 $718,048 - $952,154	92,532 Added 5.16%	1,886,396 $19 Million
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $942,215 - $2.54 Million	103,087 Added 6.1%	1,793,864 $16.8 Million
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $3.84 Million - $4.51 Million	165,359 Added 10.84%	1,690,777 $41.5 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $1.32 Million - $1.82 Million	59,140 Added 4.03%	1,525,418 $35.5 Million
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $998,978 - $1.41 Million	50,049 Added 3.53%	1,466,278 $37.1 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $682,193 - $1.16 Million	37,360 Added 2.71%	1,416,229 $27.3 Million
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $2.55 Million - $3.56 Million	133,478 Added 10.72%	1,378,869 $35.1 Million
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $287,569 - $542,975	13,571 Added 1.1%	1,245,391 $32 Million
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $1.12 Million - $1.95 Million	36,062 Added 3.02%	1,231,820 $51.6 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $991,788 - $1.55 Million	28,418 Added 2.43%	1,195,758 $52 Million
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $3.48 Million - $4.59 Million	89,918 Added 8.35%	1,167,340 $55.2 Million
Q1 2021 May 12, 2021	BUY	$26.34 - $83.07 $2.92 Million - $9.22 Million	111,047 Added 11.49%	1,077,422 $55.2 Million
Q4 2020 Feb 12, 2021	BUY	$25.51 - $43.38 $1.33 Million - $2.26 Million	52,065 Added 5.69%	966,375 $25.9 Million
Q3 2020 Nov 13, 2020	BUY	$28.28 - $53.6 $14.8 Million - $28.1 Million	524,887 Added 134.79%	914,310 $31.4 Million
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $7.62 Million - $13.1 Million	273,143 Added 234.9%	389,423 $16 Million
Q1 2020 May 14, 2020	BUY	$12.04 - $60.2 $975,252 - $4.88 Million	81,001 Added 229.6%	116,280 $3.98 Million
Q4 2019 Feb 13, 2020	BUY	$11.83 - $15.85 $417,350 - $559,172	35,279 New	35,279 $443,000

Others Institutions Holding VIR

# of Institutions

231

Shares Held

90.1M

Call Options Held

1.28M

Put Options Held

235K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.31B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Vir Biotechnology, Inc. Transaction History